Glutathione-triggered drug release from nanostructures
Related Experiment Video
Updated: Apr 19, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Alfonso Latorre, Álvaro Somoza1
1Instituto Madrileno de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), & CNB-CSICIMDEA Nanociencia Associated Unit "Unidad de Nanobiotecnología", 28049 Madrid, Spain. alfonso.latorre@imdea.org.
Abstract:
The delivery of drugs can be improved with the use of different carriers, such as those based on nanoparticles. The nanostructures loaded with the therapeutic molecules should be able to reach the target cells and, what is more, release the drugs efficiently. Ideally, the drugs should be delivered only in the target cells, and not along their way to the cells. For these reasons several approaches have been developed to control the release of the drugs at the desired sites. In this review article we have summarized the reports that describe the use of glutathione to trigger the release of the therapeutic molecules from different nanostructures.
More Related Videos
09:57A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
12:00Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation
Published on: February 24, 2016
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Classification